Steroids and derivatives
Chem-Impex International, Inc. Chenodeoxycholic acid | 474-25-9 | MFCD00064142 | 250G
Chenodeoxycholic acid, 474-25-9, MFCD00064142, 250G
Cayman Chemical CholIc ACD MaxSpec Stndard
A quantitative analytical standard guaranteed to meet MaxSpec identity, purity, stability, and concentration specifications
Chem-Impex International, Inc. Chenodeoxycholic acid | 474-25-9 | MFCD00064142 | 25G
Chenodeoxycholic acid, 474-25-9, MFCD00064142, 25G
![eMolecules 345909-26-4 | Sodium taurocholate dihydrate | Combi-Blocks | MFCD00150132 | 573.720 | C26H48NNaO9S | 96.000 | O.O.[Na+].C[C@H](CCC(=O)NCCS([O-])(=O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)CC4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C | 1g | 401040224](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502227033.JPG-250.jpg)
eMolecules 345909-26-4 | Sodium taurocholate dihydrate | Combi-Blocks | MFCD00150132 | 573.720 | C26H48NNaO9S | 96.000 | O.O.[Na+].C[C@H](CCC(=O)NCCS([O-])(=O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)CC4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C | 1g | 401040224
Sodium taurocholate dihydrate | Combi-Blocks | 345909-26-4 | MFCD00150132 | 573.720 | C26H48NNaO9S | 96.000 | O.O.[Na+].C[C@H](CCC(=O)NCCS([O-])(=O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)CC4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C | 1g | 401040224
eMolecules 474-25-9 | Chenodeoxycholic acid | Chem-Impex392.580 | C24H40O4 | 98.000 | CC(CCC(O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C | 5g | 112756347
Chenodeoxycholic acid | Chem-Impex | 474-25-9392.580 | C24H40O4 | 98.000 | CC(CCC(O)=O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C | 5g | 112756347
Sigma Aldrich Fine Chemicals Biosciences Taurocholic Acid Sodium Salt Hydrate | 345909-26-4 | MFCD00150819 | 100g
Taurocholic Acid Sodium Salt Hydrate | Purity: 95% | Mol Wt: 537.68 (anhydrous basis) | 345909-26-4 | MFCD00150819 | 100g
Medchemexpress LLC Chlorindanol | 145-94-8 | 98.0% | 50 MG
Chlorindanol (7-Chloro-4-indanol) is a topical antiseptic and sanitizer. It exhibits low systemic toxicity, good skin, eyes, and genital mucosa tolerance, and is nonallergenic. It is rapidly lethal to various microorganisms in vitro, including vegetative bacteria, Trichophyton sp., C. albicans, E. histolytica cysts and trophozoites, T. vaginalis, and spermatozoa.
- Topical antiseptic or sanitizer.
- Rapidly lethal to various microorganisms in vitro.
- Exhibits low systemic toxicity.
- Good skin, eyes, and genital mucosa tolerance.
- Nonallergenic.
Cambridge Isotope Laboratories TAUROCHOLIC ACID, SODIUM SALT (2,2,4,4-D4, 98%), 10 MG
TAUROCHOLIC ACID, SODIUM SALT (2,2,4,4-D4, 98%), 10 MG
Sigma Aldrich Fine Chemicals Biosciences Cholic acid from bovine and/or ovine, >=98% | 81-25-4 | MFCD00003672 | 1KG
Cholic acid from bovine and/or ovine, >=98% | Purity: >=98% | Mol Wt: 408.57 | 81-25-4 | MFCD00003672 | 1KG
Sigma Aldrich Fine Chemicals Biosciences Cholic acid from bovine and/or ovine, >=98% | 81-25-4 | MFCD00003672 | 500G
Cholic acid from bovine and/or ovine, >=98% | Purity: >=98% | Mol Wt: 408.57 | 81-25-4 | MFCD00003672 | 500G
Sigma Aldrich Fine Chemicals Biosciences Cholic acid from bovine and/or ovine, >=98% | 81-25-4 | MFCD00003672 | 100G
Cholic acid from bovine and/or ovine, >=98% | Purity: >=98% | Mol Wt: 408.57 | 81-25-4 | MFCD00003672 | 100G
Sigma Aldrich Fine Chemicals Biosciences Cholic acid from bovine and/or ovine, >=98% | 81-25-4 | MFCD00003672 | 25G
Cholic acid from bovine and/or ovine, >=98% | Purity: >=98% | Mol Wt: 408.57 | 81-25-4 | MFCD00003672 | 25G
Medchemexpress LLC Sodium glycocholate hydrate, 98% | 338950-81-5 | 99.9% | 100 MG
Sodium glycocholate hydrate, 98% is a buffer commonly used in molecular biology and biochemical research, providing precise pH control in various experimental settings.
- Used in molecular biology and biochemical research.
- Provides precise pH control.
Cayman Chemical Arachidonic Acid MaxSpec Sta
A quantitative analytical standard guaranteed to meet MaxSpec identity, purity, stability, and concentration specifications
Cayman Chemical GlycocholIc AcId 10g
A glycine-conjugated form of cholic acid; has roles in the emulsification of fats; reduces expression of the gene encoding FXR and increases expression of the genes encoding the bile acid receptors TGR5 and S1PR2 in SNU-245 cells at 1.6 μmol/ml; increases the intracellular accumulation and cytotoxicity of epirubicin in Caco-2 cells at 250 μM, as well as decreases expression of the genes encoding MDR1, MRP1, and MRP2 when used alone or in combination with epirubicin; increases absorption of epirubicin into everted sacs of rat ileum and jejunum at 250 μM; bile acid composition ratio of glycocholic acid is elevated in bile of patients with cholangiocarcinoma compared with patients with pancreatic cancer or benign biliary diseases; serum levels are elevated in patients with hepatocellular carcinoma compared with healthy individuals